TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Mar 16, 2026
2 min read
16

Uber Technologies and Nvidia have announced a strategic partnership to deploy a fleet of robotaxis across 28 global cities by 2028. The rollout is scheduled to begin in Los Angeles and San Francisco in 2027, utilizing Nvidia's autonomous driving software on Uber's ride-hailing network.
This collaboration enters an increasingly competitive autonomous vehicle sector. Alphabet’s Waymo is currently a market leader with fully driverless services in several US cities. Meanwhile, Tesla is developing its own robotaxi service, aiming to leverage its significant manufacturing scale and camera-based approach to autonomy.
The vehicles will be powered by Nvidia’s DRIVE Hyperion platform and its Alpamayo AI model, designed for complex driving scenarios. This partnership reinforces Uber's strategy of collaborating with technology providers rather than developing its own autonomous systems, creating a diverse ecosystem on its platform.
The deployment will be phased, starting with data collection vehicles to train the AI on local conditions, followed by supervised launches, and culminating in fully driverless Level 4 operations. This global expansion marks a significant step toward commercializing autonomous ride-hailing.
Q: When will the Uber and Nvidia robotaxis launch?
A: The service will begin in 2027 in Los Angeles and San Francisco, expanding to 28 cities by 2028.
Q: What technology powers these autonomous vehicles?
A: The fleet will use Nvidia's DRIVE Hyperion platform combined with the Alpamayo reasoning-based AI model.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

18 Mar 2026
Jefferies Flips Stance on Hearing Aid Giants

18 Mar 2026
FDA Approves J&J's Psoriasis Pill, Icotyde